ASHLEE WALKER: Open Payments
NPI 1770207391 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,504 in 140 payments from 21 companies in 2025. Trend: 2023 $1,489 · 2024 $2,098 · 2025 $4,504
Food & beverage: $3,516Travel & lodging: $957Education: $31
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 5 | $1,504 |
| ABBVIE INC. | 33 | $587 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $431 |
| Janssen Biotech, Inc. | 11 | $346 |
| Ardelyx, Inc. | 11 | $287 |
| Regeneron Healthcare Solutions, Inc. | 7 | $207 |
| GENZYME CORPORATION | 9 | $187 |
| Ipsen Biopharmaceuticals, Inc | 5 | $155 |
| Lilly USA, LLC | 5 | $144 |
| Madrigal Pharmaceuticals | 9 | $142 |
Products named: DUPIXENT, TREMFYA, ENTYVIO, RINVOQ, IBSRELA, SKYRIZI, IQIRVO, OMVOH.
Industry payments across UT — which companies pay providers there.
